BioMed Research International / 2014 / Article / Tab 1

Research Article

Hypervolemia for Hypertension Pathophysiology: A Population-Based Study

Table 1

Characteristics of the study population ().

(%)

Gender
 Male1456 (71.6)
 Female578 (28.4)
Age groups
 <651870 (91.9)
 ≥65164 (8.1)
Geographical region
 Central Anatolia323 (15.9)
 Mediterranean141 (6.9)
 Aegean578 (28.4)
 East Anatolia626 (30.8)
 Southeastern Anatolia366 (18)
Measurement time
 Morning (<12 o’clock)649 (31.9)
 Afternoon (≥12 o’clock)1385 (68.1)
Disease history
 Healthy1250 (61.5)
 Diabetics240 (11.8)
 Known HT 380 (18.7)
 CAD87 (4.3)
 COPD41 (2)
 CKD47 (2.9)
Anti-HT
 ACEi/ARB96 (4.7)
 Beta blockers50 (2.5)
 CCB18 (0.9)
 Diuretics7 (0.3)

The number of subjects is crude (unadjusted) figures.
HT: hypertension, CAD: coronary artery disease, COPD: chronic obstructive pulmonary disease, CKD: chronic kidney disease, ACEi: angiotensin converting enzyme inhibitors, ARB: angiotensin receptor blockers, and CCB: calcium channel blockers.